Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe now
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About Hardman & Co.
Case Studies
Our team
News & events
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Subscribe now
Receive our latest research as soon as it is published
Investment Research & Analysis
Detailed company analysis created for specifically for investors
Tax Enhanced Services
Product reports for investors and advisors
Bespoke Services
Services for clients with specific needs
About Hardman & Co.
We are the longest-established commissioned research provider. Read our story
Case Studies
We help a wide range of clients with different needs. Read what they say about us
Our Team
Meet the Hardman & Co team members
Latest Corporate research
Our research can still be accessed for free under MIFID II.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Utilities
list companies
Titon Holdings
Building & Construction
Electiton
By
Tony Williams
16 Dec 2019
B-North
Financials
Unquoted SME lender with unique proposition
By
Mark Thomas
16 Dec 2019
Stay up-to-date with the latest research
Sign up to our newsletter
Advanced Oncotherapy
Life Sciences
Proving the accuracy and superiority of minibeams
By
Dr Gregoire Pave
04 Dec 2019
Palace Capital
Property
1H’20 results announced
By
Mike Foster
27 Nov 2019
Artificial Solutions
Technology
Conversational AI leader; customer wins continue
By
Milan Radia
27 Nov 2019
Pantheon International Plc
Financials
History of value added to portfolio by holding Pantheon
By
Mark Thomas
26 Nov 2019
Diurnal Group Plc
Life Sciences
Successful DITEST Phase I trial outcome
By
Dr Gregoire Pave
26 Nov 2019
Genedrive Plc
Life Sciences
Regulatory hurdle leaped: hearing loss assay
By
Dr Dorothea Hill
21 Nov 2019
Incanthera Ltd
Life Sciences
Realising near-term value in oncology
By
Dr Gregoire Pave
20 Nov 2019
Chamberlin Plc
Industrial
Management actions yield cautious optimism
By
Paul Singer
19 Nov 2019
Non-Standard Finance
Financials
Trading update: understand the accounting
By
Mark Thomas
18 Nov 2019
Prev
1
2
3
4
...
35
Next
